Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-04041-x, but it redirected us to https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-04041-x. The analysis below is for the second page.

Title[redir]:
Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening | BMC Medicine | Full Text
Description:
Background Bile acids (BAs) have emerged as important mediators in neuroinflammation and neurodegeneration, important features of multiple sclerosis (MS). This study aimed to examine serum BA levels in newly diagnosed people with MS (pwMS) and explore their association with disability worsening. Methods The study included 907 pwMS and 907 matched controls from the Swedish population-based EIMS cohort, with clinical follow-up data from the Swedish MS Registry. Serum BA levels were analyzed using liquid chromatography-high-resolution mass spectrometry. Differential expression analysis was used to study differences in BAs between pwMS and controls. Cox proportional-hazard models were used to assess associations between BA concentrations and confirmed disability worsening (CDW) and the risk of reaching EDSS milestones 4.0 and 6.0. Results PwMS had lower concentrations of the primary conjugated BA, glycochenodeoxycholic acid (GCDCA, log2 FC − 0.29, p = 0.009) compared to controls. In relapsing–remitting MS compared to controls, lower concentrations of primary conjugated BAs (log2 FC − 0.30, p = 8.40E − 5), secondary conjugated BAs (log2 FC − 0.18, p = 0.007), and total BAs (log2 FC − 0.22, p = 2.99E − 4) were found. Sex-specific differences were also found, with male pwMS showing more substantial BA alterations. Elevated total BA levels were associated with increased risk for CDW (HR 1.22, 95% CI 1.08–1.39), driven mainly by primary conjugated (HR 1.19, 95% CI 1.06–1.33) and secondary conjugated BAs (HR 1.21, 95% CI 1.08–1.39). Conclusions This study identified alterations in serum BA profiles in pwMS compared to controls, with strong associations between conjugated BAs and the risk of disability worsening. These findings underscore the potential role of BAs in MS pathogenesis and disability worsening, suggesting they may be promising targets for future therapeutic interventions. Further research is warranted to clarify the underlying mechanisms of these associations.

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure if the website is profiting.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

bas, pubmed, acid, article, pwms, bile, google, scholar, disability, analysis, worsening, edss, risk, conjugated, multiple, disease, sclerosis, study, table, data, concentrations, cdw, serum, cas, differences, central, metabolism, sex, acids, included, found, levels, primary, significant, swedish, reaching, smoking, receptor, spr, association, secondary, gut, observed, additional, log, increased, controls, associations, lower, compared,

Topics {✒️}

supplementary information 12916_2025_4041_moesm1_esm author information authors springer nature additional information publisher discussion sharing state privacy rights including abbreviations cox proportional-hazard models abbreviations ad rights ethics committee confirmed disability worsening high-resolution hybrid quadrupole information lars alfredsson & tomas olsson sphingosine-1-phosphate receptor 2 central nervous system cox regression results serum bile acids content jb acknowledges funding kk acknowledges funding secondary bile acids methods cohort av acknowledges funding conjugated bile acids author correspondence original author cross-sectional karmen study relapsing–remitting ms compared privacy choices/manage cookies increased gut-barrier permeability conclusions large case–control study bile salt hydrolase healthy adults–results bile acids association neurofilament light chain sample collection acknowledges funding bile acid precursors differential expression analysis national population registry process typically mediated treat multiple sclerosis progressive multiple sclerosis stratified results based nature cns autoimmunity observed

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening
         description:Bile acids (BAs) have emerged as important mediators in neuroinflammation and neurodegeneration, important features of multiple sclerosis (MS). This study aimed to examine serum BA levels in newly diagnosed people with MS (pwMS) and explore their association with disability worsening. The study included 907 pwMS and 907 matched controls from the Swedish population-based EIMS cohort, with clinical follow-up data from the Swedish MS Registry. Serum BA levels were analyzed using liquid chromatography-high-resolution mass spectrometry. Differential expression analysis was used to study differences in BAs between pwMS and controls. Cox proportional-hazard models were used to assess associations between BA concentrations and confirmed disability worsening (CDW) and the risk of reaching EDSS milestones 4.0 and 6.0. PwMS had lower concentrations of the primary conjugated BA, glycochenodeoxycholic acid (GCDCA, log2 FC − 0.29, p = 0.009) compared to controls. In relapsing–remitting MS compared to controls, lower concentrations of primary conjugated BAs (log2 FC − 0.30, p = 8.40E − 5), secondary conjugated BAs (log2 FC − 0.18, p = 0.007), and total BAs (log2 FC − 0.22, p = 2.99E − 4) were found. Sex-specific differences were also found, with male pwMS showing more substantial BA alterations. Elevated total BA levels were associated with increased risk for CDW (HR 1.22, 95% CI 1.08–1.39), driven mainly by primary conjugated (HR 1.19, 95% CI 1.06–1.33) and secondary conjugated BAs (HR 1.21, 95% CI 1.08–1.39). This study identified alterations in serum BA profiles in pwMS compared to controls, with strong associations between conjugated BAs and the risk of disability worsening. These findings underscore the potential role of BAs in MS pathogenesis and disability worsening, suggesting they may be promising targets for future therapeutic interventions. Further research is warranted to clarify the underlying mechanisms of these associations.
         datePublished:2025-04-09T00:00:00Z
         dateModified:2025-04-09T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1186/s12916-025-04041-x
         keywords:
            Multiple sclerosis
            Bile acids
            Autoimmune disorder
            Confirmed disability worsening
            Medicine/Public Health
            general
            Biomedicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12916-025-04041-x/MediaObjects/12916_2025_4041_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12916-025-04041-x/MediaObjects/12916_2025_4041_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12916-025-04041-x/MediaObjects/12916_2025_4041_Fig3_HTML.png
         isPartOf:
            name:BMC Medicine
            issn:
               1741-7015
            volumeNumber:23
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ida Erngren
               affiliation:
                     name:Uppsala University
                     address:
                        name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aina Vaivade
               affiliation:
                     name:Uppsala University
                     address:
                        name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Henrik Carlsson
               affiliation:
                     name:Uppsala University
                     address:
                        name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Asma Al-Grety
               affiliation:
                     name:Uppsala University
                     address:
                        name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Torbjörn Åkerfeldt
               affiliation:
                     name:Uppsala University
                     address:
                        name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ingrid Kockum
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Karolinska University Hospital
                     address:
                        name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Academic Specialist Center
                     address:
                        name:Academic Specialist Center, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anna Karin Hedström
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lars Alfredsson
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Karolinska Institutet
                     address:
                        name:Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Centre for Occupational and Environmental Medicine
                     address:
                        name:Centre for Occupational and Environmental Medicine, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tomas Olsson
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Karolinska University Hospital
                     address:
                        name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Academic Specialist Center
                     address:
                        name:Academic Specialist Center, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joachim Burman
               affiliation:
                     name:Uppsala University
                     address:
                        name:Department of Medical Sciences, Translational Neurology, Uppsala University, Uppsala, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kim Kultima
               affiliation:
                     name:Uppsala University
                     address:
                        name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Bile acid metabolism in multiple sclerosis is perturbed and associated with the risk of confirmed disability worsening
      description:Bile acids (BAs) have emerged as important mediators in neuroinflammation and neurodegeneration, important features of multiple sclerosis (MS). This study aimed to examine serum BA levels in newly diagnosed people with MS (pwMS) and explore their association with disability worsening. The study included 907 pwMS and 907 matched controls from the Swedish population-based EIMS cohort, with clinical follow-up data from the Swedish MS Registry. Serum BA levels were analyzed using liquid chromatography-high-resolution mass spectrometry. Differential expression analysis was used to study differences in BAs between pwMS and controls. Cox proportional-hazard models were used to assess associations between BA concentrations and confirmed disability worsening (CDW) and the risk of reaching EDSS milestones 4.0 and 6.0. PwMS had lower concentrations of the primary conjugated BA, glycochenodeoxycholic acid (GCDCA, log2 FC − 0.29, p = 0.009) compared to controls. In relapsing–remitting MS compared to controls, lower concentrations of primary conjugated BAs (log2 FC − 0.30, p = 8.40E − 5), secondary conjugated BAs (log2 FC − 0.18, p = 0.007), and total BAs (log2 FC − 0.22, p = 2.99E − 4) were found. Sex-specific differences were also found, with male pwMS showing more substantial BA alterations. Elevated total BA levels were associated with increased risk for CDW (HR 1.22, 95% CI 1.08–1.39), driven mainly by primary conjugated (HR 1.19, 95% CI 1.06–1.33) and secondary conjugated BAs (HR 1.21, 95% CI 1.08–1.39). This study identified alterations in serum BA profiles in pwMS compared to controls, with strong associations between conjugated BAs and the risk of disability worsening. These findings underscore the potential role of BAs in MS pathogenesis and disability worsening, suggesting they may be promising targets for future therapeutic interventions. Further research is warranted to clarify the underlying mechanisms of these associations.
      datePublished:2025-04-09T00:00:00Z
      dateModified:2025-04-09T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1186/s12916-025-04041-x
      keywords:
         Multiple sclerosis
         Bile acids
         Autoimmune disorder
         Confirmed disability worsening
         Medicine/Public Health
         general
         Biomedicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12916-025-04041-x/MediaObjects/12916_2025_4041_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12916-025-04041-x/MediaObjects/12916_2025_4041_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12916-025-04041-x/MediaObjects/12916_2025_4041_Fig3_HTML.png
      isPartOf:
         name:BMC Medicine
         issn:
            1741-7015
         volumeNumber:23
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ida Erngren
            affiliation:
                  name:Uppsala University
                  address:
                     name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aina Vaivade
            affiliation:
                  name:Uppsala University
                  address:
                     name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Henrik Carlsson
            affiliation:
                  name:Uppsala University
                  address:
                     name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Asma Al-Grety
            affiliation:
                  name:Uppsala University
                  address:
                     name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Torbjörn Åkerfeldt
            affiliation:
                  name:Uppsala University
                  address:
                     name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ingrid Kockum
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Karolinska University Hospital
                  address:
                     name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Academic Specialist Center
                  address:
                     name:Academic Specialist Center, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anna Karin Hedström
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lars Alfredsson
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Karolinska Institutet
                  address:
                     name:Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Centre for Occupational and Environmental Medicine
                  address:
                     name:Centre for Occupational and Environmental Medicine, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tomas Olsson
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Karolinska University Hospital
                  address:
                     name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Academic Specialist Center
                  address:
                     name:Academic Specialist Center, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joachim Burman
            affiliation:
                  name:Uppsala University
                  address:
                     name:Department of Medical Sciences, Translational Neurology, Uppsala University, Uppsala, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kim Kultima
            affiliation:
                  name:Uppsala University
                  address:
                     name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Medicine
      issn:
         1741-7015
      volumeNumber:23
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Uppsala University
      address:
         name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
         type:PostalAddress
      name:Uppsala University
      address:
         name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
         type:PostalAddress
      name:Uppsala University
      address:
         name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
         type:PostalAddress
      name:Uppsala University
      address:
         name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
         type:PostalAddress
      name:Uppsala University
      address:
         name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska University Hospital
      address:
         name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
         type:PostalAddress
      name:Academic Specialist Center
      address:
         name:Academic Specialist Center, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Centre for Occupational and Environmental Medicine
      address:
         name:Centre for Occupational and Environmental Medicine, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska University Hospital
      address:
         name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
         type:PostalAddress
      name:Academic Specialist Center
      address:
         name:Academic Specialist Center, Stockholm, Sweden
         type:PostalAddress
      name:Uppsala University
      address:
         name:Department of Medical Sciences, Translational Neurology, Uppsala University, Uppsala, Sweden
         type:PostalAddress
      name:Uppsala University
      address:
         name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ida Erngren
      affiliation:
            name:Uppsala University
            address:
               name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
               type:PostalAddress
            type:Organization
      name:Aina Vaivade
      affiliation:
            name:Uppsala University
            address:
               name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
               type:PostalAddress
            type:Organization
      name:Henrik Carlsson
      affiliation:
            name:Uppsala University
            address:
               name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
               type:PostalAddress
            type:Organization
      name:Asma Al-Grety
      affiliation:
            name:Uppsala University
            address:
               name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
               type:PostalAddress
            type:Organization
      name:Torbjörn Åkerfeldt
      affiliation:
            name:Uppsala University
            address:
               name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
               type:PostalAddress
            type:Organization
      name:Ingrid Kockum
      affiliation:
            name:Karolinska Institutet
            address:
               name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Karolinska University Hospital
            address:
               name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Academic Specialist Center
            address:
               name:Academic Specialist Center, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Anna Karin Hedström
      affiliation:
            name:Karolinska Institutet
            address:
               name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Lars Alfredsson
      affiliation:
            name:Karolinska Institutet
            address:
               name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Karolinska Institutet
            address:
               name:Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Centre for Occupational and Environmental Medicine
            address:
               name:Centre for Occupational and Environmental Medicine, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Tomas Olsson
      affiliation:
            name:Karolinska Institutet
            address:
               name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Karolinska University Hospital
            address:
               name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Academic Specialist Center
            address:
               name:Academic Specialist Center, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Joachim Burman
      affiliation:
            name:Uppsala University
            address:
               name:Department of Medical Sciences, Translational Neurology, Uppsala University, Uppsala, Sweden
               type:PostalAddress
            type:Organization
      name:Kim Kultima
      affiliation:
            name:Uppsala University
            address:
               name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
      name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
      name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
      name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
      name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
      name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
      name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
      name:Academic Specialist Center, Stockholm, Sweden
      name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
      name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
      name:Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
      name:Centre for Occupational and Environmental Medicine, Stockholm, Sweden
      name:Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
      name:The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centrum for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
      name:Academic Specialist Center, Stockholm, Sweden
      name:Department of Medical Sciences, Translational Neurology, Uppsala University, Uppsala, Sweden
      name:Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden

External Links {🔗}(324)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Foundation
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.24s.